BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 10887098)

  • 1. Detection of differentially expressed genes in lymphomas using cDNA arrays: identification of clusterin as a new diagnostic marker for anaplastic large-cell lymphomas.
    Wellmann A; Thieblemont C; Pittaluga S; Sakai A; Jaffe ES; Siebert P; Raffeld M
    Blood; 2000 Jul; 96(2):398-404. PubMed ID: 10887098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clusterin expression in malignant lymphomas: a survey of 266 cases.
    Saffer H; Wahed A; Rassidakis GZ; Medeiros LJ
    Mod Pathol; 2002 Nov; 15(11):1221-6. PubMed ID: 12429802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas.
    Drexler HG; Gignac SM; von Wasielewski R; Werner M; Dirks WG
    Leukemia; 2000 Sep; 14(9):1533-59. PubMed ID: 10994999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clusterin, a marker for anaplastic large cell lymphoma immunohistochemical profile in hematopoietic and nonhematopoietic malignant neoplasms.
    Nascimento AF; Pinkus JL; Pinkus GS
    Am J Clin Pathol; 2004 May; 121(5):709-17. PubMed ID: 15151211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the t(2;5)(p23;q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease.
    Wellmann A; Otsuki T; Vogelbruch M; Clark HM; Jaffe ES; Raffeld M
    Blood; 1995 Sep; 86(6):2321-8. PubMed ID: 7662979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clusterin is widely expressed in systemic anaplastic large cell lymphoma but fails to differentiate primary from secondary cutaneous anaplastic large cell lymphoma.
    Lae ME; Ahmed I; Macon WR
    Am J Clin Pathol; 2002 Nov; 118(5):773-9. PubMed ID: 12428799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplification of genomic DNA demonstrates the presence of the t(2;5) (p23;q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis.
    Sarris AH; Luthra R; Papadimitracopoulou V; Waasdorp M; Dimopoulos MA; McBride JA; Cabanillas F; Duvic M; Deisseroth A; Morris SW; Pugh WC
    Blood; 1996 Sep; 88(5):1771-9. PubMed ID: 8781434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cDNA arrays: gene expression profiles of Hodgkin's disease and anaplastic large cell lymphoma cell lines.
    Thorns C; Gaiser T; Lange K; Merz H; Feller AC
    Pathol Int; 2002 Sep; 52(9):578-85. PubMed ID: 12406187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of TCL1 expression in B- and T-cell lymphomas and reactive lymphoid tissues.
    Narducci MG; Pescarmona E; Lazzeri C; Signoretti S; Lavinia AM; Remotti D; Scala E; Baroni CD; Stoppacciaro A; Croce CM; Russo G
    Cancer Res; 2000 Apr; 60(8):2095-100. PubMed ID: 10786666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
    Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
    Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MUC1 (EMA) is preferentially expressed by ALK positive anaplastic large cell lymphoma, in the normally glycosylated or only partly hypoglycosylated form.
    ten Berge RL; Snijdewint FG; von Mensdorff-Pouilly S; Poort-Keesom RJ; Oudejans JJ; Meijer JW; Willemze R; Hilgers J; Meijer CJ
    J Clin Pathol; 2001 Dec; 54(12):933-9. PubMed ID: 11729213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression of napsin A in a subset of malignant lymphomas.
    Nam SJ; Kim S; Kim JE; Lim MS; Elenitoba-Johnson KS; Kim CW; Jeon YK
    Histol Histopathol; 2016 Feb; 31(2):213-21. PubMed ID: 26400099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fascin expression in diffuse large B-cell lymphoma, anaplastic large cell lymphoma, and classical Hodgkin lymphoma.
    Bakshi NA; Finn WG; Schnitzer B; Valdez R; Ross CW
    Arch Pathol Lab Med; 2007 May; 131(5):742-7. PubMed ID: 17488159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCL2 and JUNB abnormalities in primary cutaneous lymphomas.
    Mao X; Orchard G; Lillington DM; Child FJ; Vonderheid EC; Nowell PC; Bagot M; Bensussan A; Russell-Jones R; Young BD; Whittaker SJ
    Br J Dermatol; 2004 Sep; 151(3):546-56. PubMed ID: 15377339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma.
    Eckerle S; Brune V; Döring C; Tiacci E; Bohle V; Sundström C; Kodet R; Paulli M; Falini B; Klapper W; Chaubert AB; Willenbrock K; Metzler D; Bräuninger A; Küppers R; Hansmann ML
    Leukemia; 2009 Nov; 23(11):2129-38. PubMed ID: 19657361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in B cells and in subsets of B-cell lymphomas.
    Krenacs L; Himmelmann AW; Quintanilla-Martinez L; Fest T; Riva A; Wellmann A; Bagdi E; Kehrl JH; Jaffe ES; Raffeld M
    Blood; 1998 Aug; 92(4):1308-16. PubMed ID: 9694719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between classic Hodgkin lymphoma and overlapping large cell lymphoma investigated by comparative expressed sequence hybridization expression profiling.
    Vanhentenrijk V; Vanden Bempt I; Dierickx D; Verhoef G; Wlodarska I; De Wolf-Peeters C
    J Pathol; 2006 Oct; 210(2):155-62. PubMed ID: 16874743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules.
    Foss HD; Anagnostopoulos I; Araujo I; Assaf C; Demel G; Kummer JA; Hummel M; Stein H
    Blood; 1996 Nov; 88(10):4005-11. PubMed ID: 8916967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic DNA amplification and the detection of t(2;5)(p23;q35) in lymphoid neoplasms.
    Sarris AH; Luthra R; Cabanillas F; Morris SW; Pugh WC
    Leuk Lymphoma; 1998 May; 29(5-6):507-14. PubMed ID: 9643564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAX-5: a valuable immunohistochemical marker in the differential diagnosis of lymphoid neoplasms.
    Desouki MM; Post GR; Cherry D; Lazarchick J
    Clin Med Res; 2010 Jul; 8(2):84-8. PubMed ID: 20660931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.